Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
PYXS | Pyxis Oncology, Inc. | Director | $267K | Jun 7, 2024 | ||
ACRV | Acrivon Therapeutics, Inc. | Director | Mar 4, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|